Overview

Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this trial is to assess the safety after multiple s.c. (subcutaneously) doses of liraglutide in Japanese subjects with type 2 diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide